Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Heart Test Laboratories, Inc. ( (HSCS) ).
On April 30, 2026, HeartSciences Inc. held its annual meeting of stockholders for the fiscal year ended April 30, 2025, where shareholders elected Andrew Simpson as a Class III director for a three-year term and approved an increase in shares reserved under the 2023 Equity Incentive Plan to expand its equity-based compensation capacity. Investors also ratified Haskell & White LLP as the independent auditor for the fiscal year ending April 30, 2026, approved the ability to adjourn the meeting to solicit additional proxies if needed, but did not reach the required threshold to amend the certificate of formation to extend limited officer exculpation, leaving existing officer liability protections unchanged and signaling some shareholder reservations about governance changes.
The most recent analyst rating on (HSCS) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Heart Test Laboratories, Inc. stock, see the HSCS Stock Forecast page.
Spark’s Take on HSCS Stock
According to Spark, TipRanks’ AI Analyst, HSCS is a Underperform.
The score is driven primarily by very weak financial performance (minimal revenue, large losses, heavy cash burn, and elevated leverage). Technicals add pressure with a clear downtrend and negative MACD, while valuation provides limited support due to negative earnings and no dividend yield.
To see Spark’s full report on HSCS stock, click here.
More about Heart Test Laboratories, Inc.
HeartSciences Inc. operates in the medical technology sector, focusing on cardiovascular diagnostics. The company develops and commercializes devices and related technologies aimed at improving the detection and management of heart disease, targeting healthcare providers and institutions involved in cardiac care.
Average Trading Volume: 16,480
Technical Sentiment Signal: Sell
Current Market Cap: $6.5M
For an in-depth examination of HSCS stock, go to TipRanks’ Overview page.